Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01232088

Enrollment

482

Registered

2010-11-02

Start date

2010-11-30

Completion date

2011-09-30

Last updated

2015-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Labelling

Keywords

drug labelling, standardized drug syringe labelling, European ICU

Brief summary

Medication errors are common in intensive care (Valentin A et al., BMJ. 2009;338). Standardized color coded labels for user applied syringes enjoy strong support from many health professionals, thinking that this might increase patient safety. Whether this is true or not warrants further research.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

Members of the European Society of Intensive Care Medicine (ESICM)

Design outcomes

Primary

Measure	Time frame	Description
The primary objective is to assess if standardized drug syringe labelling is used in European ICUs.	A period of 90 days.	Online survey for ICU physicians (members of the ESICM).

Secondary

Measure	Time frame	Description
The second objectives is to assess 1. if standards for drug syringe labelling are similar in European ICUs and 2. if users expect that standardized drug syringe labelling should be delivered by the pharmaceutical industry.	A period of 90 days	Online survey for ICU physicians (members of the ESICM).

Countries

Germany

Outcome results